XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Interim Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 6,673 $ 10,787
Restricted cash 27 27
Other current assets 148 116
Total current assets 6,848 10,930
Fixed assets, net 280 90
Total assets 7,128 11,020
Current liabilities:    
Trade payables 194 78
Accrued liabilities 363 450
Total current liabilities 557 528
Derivative warrant liability 5 28
Total liabilities 562 556
Commitments and contingencies
Temporary equity:    
Common stock of $0.01 par value; issued and outstanding: 721,107 shares as of September 30, 2018 and December 31, 2017 500 500
Shareholders' equity:    
Preferred stock of $0.01 par value; Authorized: 1,000,000 shares as of September 30, 2018 and December 31, 2017; issued and outstanding: 550 and 4,001 shares as of September 30, 2018 and December 31, 2017, respectively [1]
Common stock of $0.01 par value; Authorized: 220,000,000 as of September 30, 2018 and December 31, 2017; issued and outstanding (**): 2,254,569 and 2,013,193 shares as of September 30, 2018, and December 31, 2017, respectively [2] 30 27
Additional paid-in capital 31,771 30,561
Accumulated deficit (25,735) (20,624)
Total shareholders' equity 6,066 9,964
Total liabilities and shareholders' equity $ 7,128 $ 11,020
[1] Less than 1
[2] December 31, 2017 share data represents the number of shares adjusted to retroactively reflect the 1:15 reverse stock split effected on September 4, 2018.